Suzuken Co., Ltd. (TYO:9987)

Market Cap	377.76B
Revenue (ttm)	2.40T
Net Income (ttm)	34.50B
Shares Out	71.74M
EPS (ttm)	454.57
PE Ratio	11.58
Forward PE	11.93
Dividend	100.00 (1.89%)
Ex-Dividend Date	Mar 28, 2025

Volume	184,300
Average Volume	248,345
Open	5,274.00
Previous Close	5,266.00
Day's Range	5,274.00 - 5,330.00
52-Week Range	4,406.00 - 5,549.00
Beta	0.18
RSI	56.85
Earnings Date	May 13, 2025

About Suzuken

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies. The Pharmaceutical Manufacturing Business se...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1932
• Employees: 13,086
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9987

Financial Performance

In 2024, Suzuken's revenue was 2.40 trillion, an increase of 0.56% compared to the previous year's 2.39 trillion. Earnings were 34.50 billion, an increase of 18.89%.